It appears that a significant number of the symptomatic strokes resulting in neurological deficits following VAI are attributable to the initial blunt traumatic injury. The majority of patients with VAI are asymptomatic, including a number of patients with incidental cerebellar and posterior circulation strokes found on imaging studies at the time of diagnosis or in follow-up. To date, there has been no definitive longitudinal study defining the stroke risk of VAI, asymptomatic or otherwise, among patients being treated for known VAI and/or among patients receiving "no treatment" for known VAI. There is no Class I or Class II medical evidence on the issue of therapy for VAI. Class III medical evidence suggests that a small number of patients with VAI will develop a posterior circulation stroke in delayed fashion beyond deficits associated with the initial traumatic injury. While no conclusive medical evidence supports treatment for VAI, most clinicians support treatment for patients with symptomatic VAI with either anticoagulation or antiplatelet therapy. Because of an increased relative risk of hemorrhagic complications from anticoagulation therapy for VAI, without clear superior efficacy, anticoagulation therapy is not considered ideal treatment in multiple trauma patients with VAI, symptomatic or asymptomatic. Antiplatelet therapy (aspirin the most studied) appears to be a safe and comparable option for symptomatic patients with VAI after blunt trauma.
No treatment or antiplatelet therapy appears to be a comparable option for the treatment of asymptomatic patients with documented VAI. Because antiplatelet therapy has the potential to reduce future stroke risk, treatment with aspirin for documented VAI after trauma should be considered in patients if there exist no contraindications to antiplatelet therapy. At present, the choice of therapy, if any, for patients with VAI should be individualized based on the patient's VAIs, associated traumatic injuries, and the relative risk of bleeding associated with that form of therapy. e Patients treated 1 way (e.g., halo vest orthosis) compared with a group of patients treated in another way (e.g., internal fixation) at the same institution.
f The study was started after the first patient was enrolled.
g Patients identified for the study on the basis of their outcome, called "cases" (e.g., failed fusion), are compared with those who did not have outcome, called "controls" (e.g., successful fusion).
h Patients treated 1 way with no comparison group of patients treated in another way.
Levels of Recommendation
Level I
Generally accepted principles for patient management, which reflect a high degree of clinical certainty (usually this requires Class I evidence which directly addresses the clinical questions or overwhelming Class II evidence when circumstances preclude randomized clinical trials) A National Library of Medicine (PubMed) computerized literature search of publications from 1966 to 2011 was performed using the following headings: vertebral artery injury, vertebral artery dissection, cervical fracture, and cervical dislocation. The search was limited to the English language and human subjects and identified 2,226 citations. The titles and abstracts of these references were reviewed to determine relevance. Isolated case reports, small case series, editorials, letters to the editor, and review articles were eliminated. The bibliographies of the resulting fulltext articles were searched for other relevant citations.
Number of Source Documents
A total of 37 articles met inclusion criteria and 21 key citations are summarized in Evidentiary Table format (see Tables 4 and 5 in the original guideline document).
Methods Used to Assess the Quality and Strength of the Evidence
Weighting According to a Rating Scheme (Scheme Given) e Patients treated 1 way (e.g., halo vest orthosis) compared with a group of patients treated in another way (e.g., internal fixation) at the same institution.
Methods Used to Analyze the Evidence Systematic Review with Evidence Tables
Description of the Methods Used to Analyze the Evidence Selected articles were carefully reviewed by the authors. Evidentiary tables were created (refer to Tables 4 and 5 in the original guideline document) that reflected the strengths and weaknesses of each article.
On occasion, the assessed quality of the study design was so contentious and the conclusions so uncertain that the guideline authors assigned a lower medical evidence classification than might have been expected without such a detailed review. In every way, adherence to the Institute of Medicine's criteria for searching, assembling, evaluating, and weighing the available medical evidence and linking it to the strength of the recommendations presented in this document was carried out.
Articles that did not achieve immediate consensus among the author group were discussed extensively until a consensus was reached. Very few contributions required extensive discussion. Most articles were easily designated as containing Class I, II, or III medical evidence using the criteria set forth by the author group at the initiation of the literature evaluation process (see the "Rating Scheme for the Strength of the Evidence" field).
Methods Used to Formulate the Recommendations
Expert Consensus
Description of Methods Used to Formulate the Recommendations
The current author group was selected for its expertise in spinal surgery (both neurosurgical and orthopedic), neurotrauma, clinical epidemiology, and, in several cases, prior experience with guideline development. The topics chosen for inclusion in this iteration of these guidelines are contemporary and pertinent to the assessment, evaluation, care, and treatment of patients with acute cervical spine and/or spinal cord injuries.
Rating Scheme for the Strength of the Recommendations Catheter angiography is an invasive and labor-intensive procedure, is not always readily available, and has a low, but finite risk.
Because of an increased relative risk of hemorrhagic complications from anticoagulation therapy for vertebral artery injuries (VAI), without clear superior efficacy, anticoagulation therapy is not considered ideal treatment in multiple trauma patients with VAI, symptomatic or asymptomatic.
Contraindications Contraindications
Traumatic vertebral artery injury (VAI) occurs in multiple injured trauma patients and is more likely to occur in association with the most severe cervical spine and spinal cord injuries-all of which represent relative contraindications to anticoagulation and antiplatelet therapies in the treatment of potential posterior distribution stroke. The need for dual antiplatelet therapy after endovascular procedures and their potential for bleeding complications is a relative contraindication to the application of endovascular therapy in multiple injury trauma patients with VAI.
Qualifying Statements Qualifying Statements
Medical evidence-based guidelines are not meant to be restrictive or to limit a clinician's practice. They chronicle multiple successful treatment options (for example) and stratify the more successful and the less successful strategies based on scientific merit. They are not absolute, "must be followed" rules. This process may identify the most valid and reliable imaging strategy for a given injury, for example, but because of regional or institutional resources, or patient co-morbidity, that particular imaging strategy may not be possible for a patient with that injury. Alternative acceptable imaging options may be more practical or applicable in this hypothetical circumstance. Guidelines documents are not tools to be used by external agencies to measure or control the care provided by clinicians. They are not medical-legal instruments or a "set of certainties" that must be followed in the assessment or treatment of the individual pathology in the individual patients we treat. While a powerful and comprehensive resource tool, guidelines and the recommendations contained therein do not necessarily represent "the answer" for the medical and surgical dilemmas faced with many patients.
